Micro Emerging Active

Ovid Therapeutics OV329 development

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Summary

An article belongs to this narrative if it covers Ovid Therapeutics' OV329 drug candidate, its potential advantages over existing treatments, and the company's funding efforts.

Related Articles

Here's Why Ovid Therapeutics Stock Popped Higher Today

Nasdaq · Mar 18, 2026

Sources

Here's Why Ovid Therapeutics Stock Popped Higher Today Nasdaq

Timeline

Last Updated Mar 18, 2026